Emcure doubling down on biosimilars pipeline: MD Satish Mehta

strong growth

In the fiscal year, Emcure increased its revenue from operations by 16.6% year-on-year. ₹Earnings before interest, tax, depreciation and amortization (EBITDA) increased by 21.8% to Rs 9,204 million. ₹1,789 crore. EBITDA margin for the year was 19.4%, while profit after tax increased by 33.1%. ₹941 crore.